Scott L. Tarriff

Eagle Pharma gets tentative FDA approval for Lilly’s Alimta version Eagle Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration tentatively approved its diluted version of Eli Lilly and Co’s blockbuster cancer drug Alimta. The company’s shares, which gained as much as 4.8 percent, closed up 2.9 percent […]